ClaimCave

Pre-Authorization

Prior auth requirements and denials

Anthem Blue Cross Blue Shield Ohio denied my sister's prior authorization for axicabtagene ciloleucel (Yescarta) CAR-T cell therapy for relapsed refractory diffuse large B-cell lymphoma as "investigational or experimental" despite FDA approval on this exact indication since 2017, on the theory that CAR-T therapy is not "medical necessity" for her specific clinical presentation because she had not yet completed a third-line chemotherapy trial (which her oncologist at James Cancer Hospital at Ohio State documented as clinically inappropriate given her failed responses to R-CHOP and R-ICE and her disease progression on imaging), and my question is how the ERISA urgent-appeal process under 29 CFR 2560.503-1(f)(2)(i) works when the plan's medical director has denied urgent-appeal characterization despite the treating oncologist's written certification that a 72-hour decision is required because of disease progression risk, how the Ohio Department of Insurance external review through the state IRO process under RC 3922 interacts with the ERISA appeal path, what a properly built medical necessity file looks like when the underlying issue is the plan's misapplication of an "investigational" exclusion to an FDA-approved therapy, and whether there is a specialty-pharmacy versus medical-benefit routing dispute embedded in the denial (Anthem's denial letter references "specialty pharmacy formulary" language that does not appear to apply to CAR-T which is delivered through the medical benefit rather than the pharmacy benefit). the treatment center has a 21-day window to schedule her leukapheresis before the disease progression makes the CAR-T pathway unavailable. asking with the second denial letter on my kitchen counter and the treating oncology team drafting the letter of medical necessity for the external review filing.

my sister is 39 years old, a licensed physical therapist in Columbus, Ohio with two young kids ages 4 and 7, and she was diagnosed in September 2025 with diffuse large B-cell lymphoma (DLBCL), stage...

Posted by hopefulClaimant644•
4 comments

UnitedHealthcare denied prior authorization for the biologic my rheumatologist ordered for my rheumatoid arthritis, requiring me to "fail first" on two cheaper drugs, one of which i already took and failed for six months under a previous insurer and one of which my own liver labs contraindicate, the peer-to-peer they offered was a family medicine physician reviewing a rheumatology decision, my hands are measurably worse every month this drags on, and HR just told me our plan is self-funded, which apparently decides whether Illinois's step therapy override law even applies to me. how do i force the override, build an internal appeal that survives, and get to external review before the joint damage becomes permanent?

diagnosed with rheumatoid arthritis in february, age 41, after most of a year of being told i was too young for my hands to hurt like this. my rheumatologist, who took four months to get in to see,...

Posted by stressedParent271•
6 comments

aetna terminated my approved Entyvio infusions for Crohns disease after 3 years of stable continuous approvals, citing "new step therapy" requirements - but i already failed step therapy on Humira and 6MP at initial diagnosis in 2023. how do i invoke continuation-of-care and non-medical-switching protections to keep my biologic without restarting the protocol from scratch?

looking for community guidance on what feels like a textbook non-medical-switching denial. i have been stable on a biologic for 3 years and the carrier is now trying to force me back through a...

Posted by annoyed_claimant_120•
6 comments

Anthem Blue Cross denied my 9-year-old daughter's pre-auth for an MRI to diagnose pediatric epilepsy claiming an EEG was 'sufficient first-line imaging' even though her pediatric neurologist explicitly ordered the MRI to rule out a structural lesion. Won the urgent external review in 11 days under the ACA-mandated process by citing the AAN practice parameters and the NCCN imaging guidance. The three-step framework that flips pre-auth denials

Posting this because pre-authorization denials on diagnostic imaging are one of the most common and most successfully appealed health insurance disputes, and the framework for reversal is much more...

Posted by frustrated_policyholder•
6 comments

BCBS Texas denied pre-authorization for my husband's two-level lumbar fusion citing 'failure to complete conservative care.' We have 14 months of PT, three ESI rounds, and a failed RFA. The clinical reviewer is a family practice doctor with zero spine surgery training. How do I fight this peer-to-peer?

My husband is 52, an HVAC technician in Fort Worth, with documented L4-L5 and L5-S1 disc herniations confirmed on two separate MRIs eight months apart. The second MRI shows progression with new...

Posted by stressedpolicyholder341•
5 comments